Cazzola M - Search Results

1

Ruxolitinib for essential thrombocythemia refractory to or intolerant of hydroxyurea: long-term phase 2 study results.

Verstovsek S, Passamonti F, Rambaldi A, Barosi G, Rumi E, Gattoni E, Pieri L, Zhen H, Granier M, Assad A, Cazzola M, Kantarjian HM, Barbui T, Vannucchi AM. Verstovsek S, et al. Among authors: cazzola m. Blood. 2017 Oct 12;130(15):1768-1771. doi: 10.1182/blood-2017-02-765032. Epub 2017 Aug 21. Blood. 2017. PMID: 28827411 Free PMC article. Clinical Trial. No abstract available.

2

Recombinant human erythropoietin is effective in correcting erythropoietin-deficient anaemia after allogeneic bone marrow transplantation.

Locatelli F, Pedrazzoli P, Barosi G, Zecca M, Porta F, Liberato L, Gambarana D, Nespoli L, Cazzola M. Locatelli F, et al. Among authors: cazzola m. Br J Haematol. 1992 Apr;80(4):545-9. doi: 10.1111/j.1365-2141.1992.tb04571.x. Br J Haematol. 1992. PMID: 1581240

3

Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial.

Cazzola M, Ponchio L, Beguin Y, Rosti V, Bergamaschi G, Liberato NL, Fregoni V, Nalli G, Barosi G, Ascari E. Cazzola M, et al. Blood. 1992 Jan 1;79(1):29-37. Blood. 1992. PMID: 1728318 Free article. Clinical Trial.

4

An atypical myeloproliferative disorder with high thrombotic risk and slow disease progression.

Barosi G, Buratti A, Costa A, Liberato LN, Balduini C, Cazzola M, Rosti V, Magrini U, Ascari E. Barosi G, et al. Among authors: cazzola m. Cancer. 1991 Nov 15;68(10):2310-8. doi: 10.1002/1097-0142(19911115)68:10<2310::aid-cncr2820681034>3.0.co;2-2. Cancer. 1991. PMID: 1913467

5

Effects of recombinant alpha and gamma interferons on the in vitro growth of circulating hematopoietic progenitor cells (CFU-GEMM, CFU-Mk, BFU-E, and CFU-GM) from patients with myelofibrosis with myeloid metaplasia.

Carlo-Stella C, Cazzola M, Gasner A, Barosi G, Dezza L, Meloni F, Pedrazzoli P, Hoelzer D, Ascari E. Carlo-Stella C, et al. Among authors: cazzola m. Blood. 1987 Oct;70(4):1014-9. Blood. 1987. PMID: 3115331 Free article.

6

Natural history of idiopathic refractory sideroblastic anemia.

Cazzola M, Barosi G, Gobbi PG, Invernizzi R, Riccardi A, Ascari E. Cazzola M, et al. Blood. 1988 Feb;71(2):305-12. Blood. 1988. PMID: 3337899 Free article.

7

Intravenous iron therapy for severe anaemia in systemic-onset juvenile chronic arthritis.

Martini A, Ravelli A, Di Fuccia G, Rosti V, Cazzola M, Barosi G. Martini A, et al. Among authors: cazzola m. Lancet. 1994 Oct 15;344(8929):1052-4. doi: 10.1016/s0140-6736(94)91710-8. Lancet. 1994. PMID: 7864944 Clinical Trial.

8

Guidelines for the use of recombinant human erythropoietin.

Barosi G, Cazzola M, De Vincentiis A, Grossi A, Tura S. Barosi G, et al. Among authors: cazzola m. Haematologica. 1994 Nov-Dec;79(6):526-33. Haematologica. 1994. PMID: 7896210 No abstract available.

9

Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis.

Cazzola M, Ponchio L, de Benedetti F, Ravelli A, Rosti V, Beguin Y, Invernizzi R, Barosi G, Martini A. Cazzola M, et al. Blood. 1996 Jun 1;87(11):4824-30. Blood. 1996. PMID: 8639855 Free article.

10

Use of recombinant human erythropoietin outside the setting of uremia.

Cazzola M, Mercuriali F, Brugnara C. Cazzola M, et al. Blood. 1997 Jun 15;89(12):4248-67. Blood. 1997. PMID: 9192747 Free article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,247 results

Search Page

Filters